Article

Oertli launches its SwissTech phaco system at ESCRS

Oertli Instruments AG, Berneck, Switzerland, introduces the SwissTech phaco machine, the successor to its well-established CataRhex phacoemulsification machine, at the European Society of Cataract and Refractive Surgeons (ESCRS) meeting.

Oertli Instruments AG, Berneck, Switzerland, introduces the SwissTech phaco machine, the successor to its well-established CataRhex phacoemulsification machine, at the European Society of Cataract and Refractive Surgeons (ESCRS) meeting.

Company officials report that the portable SwissTech phaco machine brings "higher intelligence" in the performance of cataract surgery. The unit offers little over-engineering and user-proven physical concepts. It eliminates unnecessary features, yet allows for fast, easy-to-learn operation of the machine. Procedures with SwissTech are said to be more economical, at different sites and requiring less space, weighing 5.6 kg (12.3 pounds).

Performance of the SwissTech includes chamber stability at a state-of-the-art level, CMP cool phaco for micro-incision cataract surgery, an occlusion mode, 40 Hz micro pulse, paramount pedal control, and individual programming for nine surgeons. The pressure sensor is a closed system, which eliminates the risk of contamination. The SwissTech also can be extended to posterior segment surgery when in its Vitrex module.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.